NYSE CRTR Economy Event Watch the replay →

Advertisement
Advertisement

XHEvsBBPETF Comparison

ETF 1
XHE

State Street SPDR S&P Health Care Equipment ETF

This fund is part of
US Health Care
-0%
VS
ETF 2
BBP

Virtus LifeSci Biotech Products ETF

This fund is part of
Tomorrow's Treatments
+0.67%

State Street SPDR S&P Health Care Equipment ETF (XHE) belongs to the US Health Care segment. Virtus LifeSci Biotech Products ETF (BBP) is part of the Tomorrow's Treatments segment. Both ETFs have the same top 3 sector exposures: and Health Care. XHE is less expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.79% for BBP. XHE is down -6.98% year-to-date (YTD) with -$535K in YTD flows. BBP performs better with 9.25% YTD performance, and +$30M in YTD flows. Run a side-by-side ETF comparison of XHE and BBP below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

XHE vs BBP performance and flow charts

Performance

-6.0-4.0-2.00.02.04.06.0%May 12May 19May 26Jun 2Jun 9

Cumulative Flows

0 M5 M10 M15 MMay 12May 19May 26Jun 2Jun 9

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 06/12/2026
1M3MYTD1Y3Y5Y
Perf.
XHE
BBP
+4.32%-1.38%
+2.70%+7.00%
-6.98%+9.25%
+0.63%+43.65%
-13.93%+60.05%
-34.60%+58.90%
Flows
XHE
BBP
+$14M+$4M
+$4M+$26M
-$535K+$30M
-$33M+$42M
-$319M+$45M
-$381M+$38M
Volatility and drawdown
3M1Y3Y5Y
Volatility
XHE
BBP
+25.26%+28.75%
+21.83%+24.06%
+21.71%+24.00%
+24.47%+26.36%
Max drawdown
XHE
BBP
-8.81%-7.49%
-18.20%-9.59%
-32.46%-25.54%
-49.90%-37.87%
Max drawdown duration
XHE
BBP
54d37d
155d48d
1061d292d
1744d760d
Trading data

Create an account to view trading data

Join for free
XHE
BBP
Last sale
6/12/2026 at 1:30 PM
$81.88
$87.17
Previous close
06/11/2026
$82.05
$86.80
Consolidated volume
06/11/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of May 29, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
XHE
BBP
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 6/12/2026 at 1:30 PM
Live
Closed
XHE
BBP
Last price
$81.88
$87.17
1D performance
-0.21%
+0.42%
AuM$143.46 M$78.43 M
E/R0.35%0.79%
Characteristics
XHE
BBP
Management strategyPassivePassive
ProviderState Street Investment ManagementVIRTUS Investment Partners
BenchmarkS&P Health Care Equipment Select Industry IndexLifeSci Biotechnology Products Index
N° of holdings6055
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateJanuary 26, 2011December 16, 2014
ESGNoNo
Advertisement
Exposure

Countries

XHE
USA
92.03%
Other
7.97%
BBP
USA
84.13%
Other
15.87%

Sectors

XHE
Health Care
89.92%
Other
10.08%
BBP
Health Care
85.97%
Other
14.03%
Advertisement

Diversification

XHE

Total weight of top 15 holdings out of 15

29.69%
BBP

Total weight of top 15 holdings out of 15

45.32%

Top 15 holdings

Data as of April 30, 2026
XHE
STAAR SURGICAL
2.55%
GLAUKOS
2.39%
AXOGEN
2.29%
BUTTERFLY NETWORK INC
2.14%
NOVOCURE LTD
2.07%
AVANOS MEDICAL INC
2.05%
TELEFLEX
1.89%
OMNICELL
1.89%
IRHYTHM TECHNOLOGIES
1.84%
US58507V1070
1.79%
INTEGER HOLDINGS
1.78%
GLOBUS MEDICAL
1.77%
LANTHEUS HOLDINGS
1.76%
MASIMO
1.74%
LEMAITRE VASCULAR
1.73%
BBP
ARROWHEAD PHARMACEUTICALS INC
3.17%
GB00BRXB0C07
3.17%
BIOGEN INC
3.14%
HALOZYME THERAPEUTICS
3.13%
AURINIA PHARMACEUTICALS INC
3.12%
SYNDAX PHARMACEUTICALS INC
3.12%
BIOMARIN PHARMACEUTICAL
3.05%
REGENERON PHARMACEUTICALS
3.03%
INCYTE
3.03%
BRIDGEBIO PHARMA
3.00%
SAREPTA THERAPEUTICS INC DE
2.95%
ARDELYX
2.92%
VERTEX PHARMACEUTICALS
2.85%
US07725L1026
2.83%
THERAVANCE BIOPHARMA
2.80%
Frequently asked questions about XHE and BBP

How have the XHE and BBP ETFs performed in 2026?

As of June 12, 2026, XHE is down -6.98% year-to-date (YTD), while BBP has returned 9.25%. That puts BBP better performer ahead so far this year.

Which ETF is attracting more investor money: XHE or BBP?

Year-to-date, the XHE ETF saw -$535K in flows, compared to +$30M for BBP.

Which ETF is more volatile: XHE or BBP?

Over the past year, XHE had a volatility of 21.83%, while BBP experienced 24.06%.

Which ETF is bigger: XHE or BBP?

As of June 12, 2026, XHE holds $143.46 M in assets under management (AUM), while BBP manages $78.43 M.

What sectors do the XHE and BBP ETFs invest in?

XHE leans toward sectors like Health Care. Meanwhile, BBP focuses on Health Care.

What are the top holdings of the XHE ETF and BBP ETF?

XHE top holdings include STAAR SURGICAL, GLAUKOS and AXOGEN. BBP holds in its top three: ARROWHEAD PHARMACEUTICALS INC, GB00BRXB0C07 and BIOGEN INC.

Which ETF is more diversified: XHE or BBP?

XHE holds 66 securities with 29.69% of its assets in the top 15. BBP has 59 securities and a top 15 weight of 45.32%.

Advertisement
Advertisement
Advertisement
The Active Trader Report

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up